Eric J. Tarcha

Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial

Eric J. Tarcha, Chelsea M. Olsen, Peter Probst et al. · PLoS ONE · 2017 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease

Eric J. Tarcha, Victor Chi, Ernesto J. Muñoz‐Elías et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 116 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Phylogenetic Analysis of <i>Lacazia loboi</i> Places This Previously Uncharacterized Pathogen within the Dimorphic Onygenales

Roger A. Herr, Eric J. Tarcha, Paulo R. Taborda et al. · Journal of Clinical Microbiology · 2001 · 113 citations · Full text

Life Sciences, Biology, Microbiology +17

Evolution of the Mating Type Locus: Insights Gained from the Dimorphic Primary Fungal Pathogens <i>Histoplasma capsulatum</i> , <i>Coccidioides immitis</i> , and <i>Coccidioides posadasii</i>

James A. Fraser, Jason Stajich, Eric J. Tarcha et al. · Eukaryotic Cell · 2007 · 91 citations · Full text

Life Sciences, Genetics, Microbiology +17

A Recombinant Aspartyl Protease of<i>Coccidioides posadasii</i>Induces Protection against Pulmonary Coccidioidomycosis in Mice

Eric J. Tarcha, Venkatesha Basrur, Chiung-Yu Hung et al. · Infection and Immunity · 2005 · 69 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17